1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Optigenex Inc.

Optigenex Inc.

OPGX
Optigenex Inc.US flagOther OTC
0.00
USD
- -
- -
17.00Market Cap
2004 Y
2005 Y
2006 Y
2007 Y
TTM
Revenue per Share
- -
- -
- -
- -
1,432.3
Basic EPS, GAAP
- -
- -
- -
- -
-8,831.74
Free Cash Flow per Basic Share
- -
- -
- -
- -
-398.15
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
-64,112.78
Tangible Book Value per Share
- -
- -
- -
- -
-26,027.57
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
1
Operating Margin (%)
-1,708.57
-2,244.34
-1,629.23
-298.48
-178.32
Depreciation Expense
- -
1
2
- -
- -
Net Income, GAAP
-6
-7
-7
-3
-4
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
-1,708.57
-2,518.13
-2,444.96
-621.88
-616.61
Working Capital
3
3
1
-5
-8
LT Debt
- -
3
6
4
3
Total Equity
7
2
-5
-8
-10
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'07
Mar'08
Jun'08
ST Debt
5
9
8
LT Borrowings
4
3
3
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Dec'07
Mar'08
Jun'08
Total Current Assets
1
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
5
10
9
Payables & Accruals
- -
1
- -
ST Debt
5
9
8
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
58.4%
Free Cash Flow
- -
- -
-84.44%
Net Income, GAAP
- -
- -
-60.61%
Sales/Revenue/Turnover
- -
- -
54.85%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
-8,262.38
2,290.29
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Daniel Zwiren
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Address
901 Sam Rayburn Highway Melissa TX United States of America 75454
IPO Date
Sep 20, 2012
Website
optigenex.com
Similar Companies
Insight Molecular Diagnostics Inc. (0KCC.L)
Standard BioTools Inc. (FLDM)
StageZero Life Sciences Ltd. (SZLSF)
Hypha Labs, Inc. (FUNI)
Chembio Diagnostics, Inc. (CEMI)
IDEXX Laboratories, Inc. (IDXX)
Business
Optigenex Inc. operates in the specialized field of applied sciences, providing advanced solutions for healthy age management and cellular wellness. The company's flagship offering is AC-11, a proprietary and patented botanical extract sourced sustainably from the Amazon rainforest. This unique, water-soluble compound, derived from the *Uncaria tomentosa* vine, is recognized for its ability to bolster the body's intrinsic capacity for DNA repair, address damage from environmental and sun exposure, and diminish the progression of skin aging. Supported by extensive research and numerous studies, AC-11 also contributes to immune system enhancement, neural function improvement, and the maintenance of telomere integrity, alongside promoting natural collagen production for skin vitality. Optigenex licenses and supplies this innovative technology to manufacturers, distributors, and retailers globally, serving the dietary supplement, anti-aging topical skincare, cosmetic, and cosmeceutical industries. The company is based in Melissa, Texas.